SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062145
Filing Date
2023-11-09
Accepted
2023-11-09 16:32:57
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q virx-20230930.htm   iXBRL 10-Q 2565177
2 EX-10.1 virx-ex10_1.htm EX-10.1 15856
3 EX-10.2 virx-ex10_2.htm EX-10.2 139257
4 EX-31.1 virx-ex31_1.htm EX-31.1 11708
5 EX-31.2 virx-ex31_2.htm EX-31.2 11720
6 EX-32.1 virx-ex32_1.htm EX-32.1 5317
7 EX-32.2 virx-ex32_2.htm EX-32.2 5253
  Complete submission text file 0000950170-23-062145.txt   9371388

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT virx-20230930_cal.xml EX-101.CAL 40152
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT virx-20230930_def.xml EX-101.DEF 279943
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT virx-20230930_pre.xml EX-101.PRE 406734
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT virx-20230930_lab.xml EX-101.LAB 543200
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT virx-20230930.xsd EX-101.SCH 64666
46 EXTRACTED XBRL INSTANCE DOCUMENT virx-20230930_htm.xml XML 1715387
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 231393143
SIC: 2834 Pharmaceutical Preparations